Paushak Share Price & Earnings Call Analysis

Financials of Paushak

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Paushak

Quarterly Results

Quarter-by-quarter operating performance

Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +56495252545257495256594955
Expenses +37363833354040353638443738
Operating Profit20121419191217151618151117
OPM %35%25%28%36%35%23%30%30%30%32%25%23%30%
Other Income +2473744602118
Interest0000000000001
Depreciation3333444444458
Profit before tax1912181823121717121611716
Tax %23%26%25%26%19%17%16%11%21%23%24%17%22%
Net Profit +14913141810141510129613
EPS in Rs5.833.725.425.547.424.195.776.203.904.893.502.505.07

Financials of Paushak

Profit & Loss

Annual income statement trend

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales +697872105140138141150212206211219
Expenses +5261607599959196137142151158
Operating Profit171712294043505475656061
OPM %25%22%17%28%29%31%36%36%35%31%28%28%
Other Income +33531376511201412
Interest000000000001
Depreciation2333445913141521
Profit before tax181714294945525072715950
Tax %28%25%22%26%20%23%28%25%25%23%16%22%
Net Profit +131211213935373854544939
EPS in Rs5.074.854.278.3915.8414.1915.1615.2921.9622.0920.0715.95
Dividend Payout %7%8%9%4%4%5%5%10%10%11%12%16%

Financials of Paushak

Balance Sheet

Capital structure and asset base

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital3333333333312
Reserves546580110174224269302351405462479
Borrowings +01010000002577
Other Liabilities +111311313643576161738192
Total Liabilities698294144214270329367415481572660
Fixed Assets +18203537384151147149152141377
CWIP1120161668872919026
Investments19183353116163154151182223139150
Other Assets +30312654545056617877102107
Total Assets698294144214270329367415481572660

Financials of Paushak

Cash Flows

Operating, investing and financing cash movement

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +91412102441304443563854
Cash from Investing Activity +-8-13-11-10-0-39-29-42-38-50-57-95
Cash from Financing Activity +-1-1-2-1-23-2-2-2-4-51942
Net Cash Flow00-0000-1-000-10
Free Cash Flow0-3751327-26-42817-122-34
CFO/OP77%104%118%56%85%116%85%98%73%107%82%97%

Financials of Paushak

Ratios

Working capital efficiency and return ratios

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days11497831358569859790909492
Inventory Days96117125118122131148233180177179292
Days Payable941047017073110118227122130167245
Cash Conversion Cycle1161101388313389115103149137107139
Working Capital Days1089292107100756081938480109
ROCE %32%25%12%29%27%21%20%17%21%17%11%10%

Others in Chemicals & Petrochemicals this season

  • Solar Industries India Ltd (Q1 FY27)

    EBITDA margin improvement potential in explosive business to reach mid-teens (18-19% global benchmarks), with combined Solar-BME margins currently at 13-14%…

  • Sudarshan Chemical Industries Ltd (Q1 FY27)

    The net debt has already been reduced significantly from Rs.922 Crores at acquisition to Rs.531 Crores. Key concall takeaways from Sudarshan Chemical…

  • Indo Borax & Chemicals Ltd (Q1 FY27)

    250-260 crores in FY27 with about 20% EBITDA margin, growing at 11-12% annually in absolute terms. Key concall takeaways from Indo Borax & Chemicals Ltd's Q1…

  • SRF Ltd (Q1 FY27)

    Chemicals business is guided for 15-20% growth in FY27, with a strong Q1 performance positioning the company to possibly hit the higher end of this range (Page…

Compare:vs Solar Industries India Ltdvs Pidilite Industries Ltdvs SRF Ltd